Table 2 Adverse event costs of advanced gastric cancer patients treated with ECX or FOLFIRI per cycle per patient.
Grade 3 to 4 | ECX (N) | FOLFIRI (N) | Cost for ECX ($) | Cost for FOLFIRI ($) |
---|---|---|---|---|
First-line | 200 | 203 | Â | Â |
 nonhematologic | 107 | 108 | 4.74 | 4.30 |
 hematologic | 129 | 78 | 13.18 | 7.18 |
 total | — | — | 17.92 | 11.48 |
Second-line | 101 | 81 | Â | Â |
 nonhematologic | 47 | 44 | 5.20 | 6.54 |
 hematologic | 44 | 35 | 11.24 | 12.00 |
 total | — | — | 16.44 | 18.54 |